Table 1 Baseline characteristics of 50 inmates treated for chronic HCV infection at national institute for infectious diseases L. Spallanzani, 2006-2009
From: HCV infected prisoners: should they be still considered a difficult to treat population?
Characteristics | Treated | |
|---|---|---|
N | % | |
All | 50 | |
Age | ||
Median (IQR) | 39 (34–43) | |
<35 | 15 | 30.0 |
35-44 | 25 | 50.0 |
≥45 | 10 | 20.0 |
Race | ||
Caucasian | 46 | 92.0 |
African | 4 | 8.0 |
BMI | ||
<25 | 24 | 48.0 |
≥25 | 26 | 52.0 |
IVDU | ||
Yes | 34 | 68.0 |
No | 16 | 32.0 |
Biopsy staging (Metavir) | ||
F1-F2 | 37 | 74.0 |
F3-F4 | 13 | 26.0 |
ALT (IU/L) | ||
<60 | 10 | 20.0 |
≥60 | 40 | 80.0 |
HCV-RNA (mU/ml) | ||
<6x105 | 18 | 36.0 |
≥6x105 | 32 | 64.0 |
HCV genotype | ||
1 | 25 | 50.0 |
Other than 1 | 25 | 50.0 |
HIV Ab | 3 | 6.0 |
Positive | 47 | 94.0 |
Negative | ||